論文

基本情報

氏名 恒富 亮一
氏名(カナ) ツネドミ リョウイチ
氏名(英語) Tsunedomi Ryouichi
所属 獣医学部 獣医学科
職名 教授
researchmap研究者コード 1000361639
researchmap機関 岡山理科大学

題名

Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer

単著・共著の別

 

著者

Taichi Kuwahara
Shoichi Hazama
Nobuaki Suzuki
Shin Yoshida
Shinobu Tomochika
Yuki Nakagami
Hiroto Matsui
Yoshitaro Shindo
Shinsuke Kanekiyo
Yukio Tokumitsu
Michihisa Iida
Ryouichi Tsunedomi
Shigeru Takeda
Shigefumi Yoshino
Naoko Okayama
Yutaka Suehiro
Takahiro Yamasaki
Tomonobu Fujita
Yutaka Kawakami
Tomio Ueno
Hiroaki Nagano

概要

BACKGROUND: CD3 +  and CD8 + T-cell infiltration were reported as positive predictive markers of survival in colorectal cancer (CRC) patients. Here, we demonstrate the prognostic significance of CD4 + and FOXP3 + T-cell densities in CRC. METHODS: We quantified the intratumoural densities of CD3 + , CD8 + , CD4 +  and FOXP3 + T cells by immunohistochemistry and digital pathology in 342 CRC patients who underwent curative resection. Microsatellite instability was also assessed in 322 specimens. Patient demographics, clinicopathological features and survival rates were analysed. RESULTS: High CD3 + , CD4 +  and FOXP3 + T-cell densities were associated with improved relapse-free survival (RFS); high CD8 + , CD4 +  and FOXP3 + T-cell densities were associated with improved disease-specific survival (DSS). Patients with low CD4 + and low FOXP3 + T-cell densities exhibited extremely poor prognoses. T stage, vascular/lymphatic invasion and CD4 + T-cell density were independent prognostic indicators for DSS. The distributions of CD4 + and FOXP3 + T-cell densities were not significantly different between the high microsatellite instability group and other groups, in contrast to those of CD3 + and CD8 + T-cell densities. CONCLUSIONS: Intratumoural CD4 + T-cell density and combined CD4 + and FOXP3 + T-cell densities were stronger prognostic indicators than other clinicopathological features. These results may facilitate the establishment of novel prognostic factors and therapeutic strategies for CRC.

発表雑誌等の名称

British Journal of Cancer

出版者

 

121

8

開始ページ

659

終了ページ

665

発行又は発表の年月

2019-10

査読の有無

有り

招待の有無

無し

記述言語

英語

掲載種別

研究論文(学術雑誌)

ISSN

 

ID:DOI

10.1038/s41416-019-0559-6

ID:NAID(CiNiiのID)

 

ID:PMID

 

JGlobalID

 

arXiv ID

 

ORCIDのPut Code

 

DBLP ID